Bone tissue engineering (BTE) has emerged as a critical solution for repairing large bone defects caused by trauma, infection ...

In recent years, there have been tremendous advances in tissue engineering, the field of biomaterials research and development that combines living cells with 3D microstructures and biologically ...

Losing a large amount of soft tissue from an injury or cancer may require reconstructive surgery. These surgeries typically rely on a structural framework that holds cells or tissues together made ...

Engineering functional cellular tissue components holds great promise in regenerative medicine. Collagen I, a key scaffolding material in bodily tissues, presents challenges in controlling its ...

A team of biomedical researchers led by Michael Mak, Ph.D., in the Renaissance School of Medicine at Stony Brook University, has developed a new method of bioprinting physiological materials. Called ...

About 25 million people in the U.S.—roughly eight out of 100—are diagnosed with asthma. Allergens, air pollution, extreme ...

Angiogenesis is a process of forming hierarchical vascular networks in living tissues. Its complexity makes the controlled generation of blood vessels in laboratory conditions a highly challenging ...

Organ failure impacts millions of patients each year and costs hundreds of billions of US Dollars. Over the last 30 years, scientists have utilized a combination of tools, methods, and molecules of ...

One of humanity’s greatest challenges is space exploration, which requires an in-depth analysis of the data continuously collected as a necessary input to fill technological gaps and move forward in ...

These fields aim to facilitate healing and restore lost function in damaged or diseased tissues and organs by integrating scaffolds, cells, and biological signaling molecules. This combination aims to ...

Anthony Atala at Harvard Medical School Cartilage; Jim Burns at Genzyme Cartilage; Antonios Mikos at Rice U. Bone and cardiovascular tissue; David Mooney at U. Michigan Bone and cartilage Every year, ...

BSF Enterprise PLC (LSE:BSFA), the tissue-engineered materials developer, saw its shares fall 31% to 2.17p after announcing a ...